A mutation in human VAP-B-MSP domain, present in ALS patients, affects the interaction with other cellular proteins

Protein Expression and Purification

Volumn 55, Issue 1, 2007, Pages 139-146

  Mitne Neto, M ^a   Ramos, C R R ^a   Pimenta, D C ^b   Luz, J S ^a   Nishimura, A L ^a   Gonzales, F A ^a   Oliveira, C C ^a   Zatz, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Amyotrophic Lateral Sclerosis; Dimerization; Protein interaction; VAP B

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROLINE; RECOMBINANT PROTEIN; SERINE; TUBULIN; UNCLASSIFIED DRUG; VAPB PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOSYNTHESIS; CHEMISTRY; ESCHERICHIA COLI; GENE DELETION; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; MUTATION; PROTEIN ANALYSIS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; CLONING, MOLECULAR; ESCHERICHIA COLI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); HUMANS; MUTATION; PROLINE; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SEQUENCE DELETION; SERINE; TUBULIN; VESICULAR TRANSPORT PROTEINS;

EID: 34547880001     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.04.007     Document Type: Article

References (31)

1. Goodall E.F., and Morrison K.E. Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev. Mol. Med. 8 (2006) 1-22
2. Hand C.K., and Rouleau G.A. Familial amyotrophic lateral sclerosis. Muscle Nerve 25 (2002) 135-159
3. Deng H.X., Shi Y., Furukawa Y., Zhai H., Fu R., Liu E., Gorrie G.H., Khan M.S., Hung W.Y., Bigio E.H., Lukas T., Dal Canto M.C., O'Halloran T.V., and Siddique T. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc. Natl. Acad. Sci. USA 103 (2006) 7142-7147
4. Lacomblez L., Bensimon G., Leigh P.N., Guillet P., Powe L., Durrleman S., Delumeau J.C., and Meininger V. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology 47 (1996) S242-S250
5. Kunst C.B. Complex genetics of amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75 (2004) 933-947
6. Gros-Louis F., Gaspar C., and Rouleau G.A. Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim. Biophys. Acta (2006)
7. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., and Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 (1998) 1851-1854
8. Nishimura A.L., Mitne-Neto M., Silva H.C., Oliveira J.R., Vainzof M., and Zatz M. A novel locus for late onset amyotrophic lateral sclerosis/motor neurone disease variant at 20q13. J. Med. Genet. 41 (2004) 315-320
9. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., Skehel P., and Zatz M. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75 (2004) 822-831
10. Nishimura Y., Hayashi M., Inada H., and Tanaka T. Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem. Biophys. Res. Commun. 254 (1999) 21-26
11. Kosinski M., McDonald K., Schwartz J., Yamamoto I., and Greenstein D. C. elegans sperm bud vesicles to deliver a meiotic maturation signal to distant oocytes. Development 132 (2005) 3357-3369
12. Amarilio R., Ramachandran S., Sabanay H., and Lev S. Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem. 280 (2005) 5934-5944
13. Weir M.L., Xie H., Klip A., and Trimble W.S. VAP-A binds promiscuously to both v- and tSNAREs. Biochem. Biophys. Res. Commun. 286 (2001) 616-621
14. Pennetta G., Hiesinger P.R., Fabian-Fine R., Meinertzhagen I.A., and Bellen H.J. Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron 35 (2002) 291-306
15. Skehel P.A., Martin K.C., Kandel E.R., and Bartsch D. A VAMP-binding protein from Aplysia required for neurotransmitter release. Science 269 (1995) 1580-1583
16. Skehel P.A., Fabian-Fine R., and Kandel E.R. Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc. Natl. Acad. Sci. USA 97 (2000) 1101-1106
17. Loewen C.J., Roy A., and Levine T.P. A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP. EMBO J. 22 (2003) 2025-2035
18. Wyles J.P., and Ridgway N.D. VAMP-associated protein-A regulates partitioning of oxysterol-binding protein-related protein-9 between the endoplasmic reticulum and Golgi apparatus. Exp. Cell Res. 297 (2004) 533-547
19. Kaiser S.E., Brickner J.H., Reilein A.R., Fenn T.D., Walter P., and Brunger A.T. Structural basis of FFAT motif-mediated ER targeting. Structure 13 (2005) 1035-1045
20. Hamamoto I., Nishimura Y., Okamoto T., Aizaki H., Liu M., Mori Y., Abe T., Suzuki T., Lai M.M., Miyamura T., Moriishi K., and Matsuura Y. Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J. Virol. 79 (2005) 13473-13482
21. Kanekura K., Nishimoto I., Aiso S., and Matsuoka M. Characterization of Amyotrophic Lateral Sclerosis-linked P56S Mutation of Vesicle-associated Membrane Protein-associated Protein B (VAPB/ALS8). J. Biol. Chem. 281 (2006) 30223-30233
22. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13 (1999) 1211-1233
23. Ramos C.R., Abreu P.A., Nascimento A.L., and Ho P.L. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz. J. Med. Biol. Res. 37 (2004) 1103-1109
24. Westermeier R., and Naven T. Proteomics in Practice (2002), WILEY-VCH, Weinheim
25. Loewen C.J., and Levine T.P. A highly conserved binding site in vesicle-associated membrane protein-associated protein (VAP) for the FFAT motif of lipid-binding proteins. J. Biol. Chem. 280 (2005) 14097-14104
26. Alberts B., Bray D., Lewis J., Raf M., Roberts K., and Watson J.D. Molecular Biology of the Cell. Third ed. (1994), Garland Publishing
27. Schonhoff C.M., Matsuoka M., Tummala H., Johnson M.A., Estevez A.G., Wu R., Kamaid A., Ricart K.C., Hashimoto Y., Gaston B., Macdonald T.L., Xu Z., and Mannick J.B. S-nitrosothiol depletion in amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 103 (2006) 2404-2409
28. Chuang D.M., Hough C., and Senatorov V.V. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 269-290
29. Tatton W.G., Chalmers-Redman R.M., Elstner M., Leesch W., Jagodzinski F.B., Stupak D.P., Sugrue M.M., and Tatton N.A. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling 60 (2000) 77-100
30. Sirover M.A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim. Biophys. Acta 1432 (1999) 159-184
31. Chuang D.M., and Ishitani R. A role for GAPDH in apoptosis and neurodegeneration. Nat. Med. 2 (1996) 609-610